Mini-review: amyloid degradation toxicity hypothesis of Alzheimer's disease
The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Nanomolar levels of soluble Aβ oligomers are known to be highly cytotoxic and mediate damage via a number of cellular pathways, including the formation of Aβ membrane channels [29,30].”
From Advances in the cell biology of the trafficking and processing of amyloid precursor protein: impact of familial Alzheimer's disease mutations (2024) · cites this paper as [29]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mitochondria as sensors and regulators of calcium signalling
Rizzuto, R., De Stefani, D., Raffaello, A., & Mammucari, C. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3412 · Cited by 1,781
Oligomeric and fibrillar species of amyloid-β peptides differentially affect neuronal viability
Dahlgren, K. N., Manelli, A. M., Stine, W. B., Baker, L. K., Krafft, G. A., & LaDu, M. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201750200 · Cited by 1,452
Neurotoxicity of Amyloid -Protein: Synaptic and Network Dysfunction
Mucke, L., & Selkoe, D. J. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006338 · Cited by 1,000
The Amyloid-β Oligomer Hypothesis: Beginning of the Third Decade
Cline, E. N., Bicca, M. A., Viola, K. L., & Klein, W. L. (2018) · Journal of Alzheimer's Disease · doi:10.3233/jad-179941 · Cited by 870
Busche, M. A., Chen, X., Henning, H. A., Reichwald, J., Staufenbiel, M., Sakmann, B., & Konnerth, A. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1206171109 · Cited by 715
FDG-PET improves accuracy in distinguishing frontotemporal dementia and Alzheimer's disease
Foster, N. L., Heidebrink, J. L., Clark, C. M., Jagust, W. J., Arnold, S. E., Barbas, N. R., DeCarli, C. S., Scott Turner, R., Koeppe, R. A., Higdon, R., et al. (2007) · Brain · doi:10.1093/brain/awm177 · Cited by 608
Common mechanisms of amyloid oligomer pathogenesis in degenerative disease
Glabe, C. G. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.04.017 · Cited by 569
2,4-Dinitrophenol (DNP): A Weight Loss Agent with Significant Acute Toxicity and Risk of Death
Grundlingh, J., Dargan, P. I., El-Zanfaly, M., & Wood, D. M. (2011) · Journal of Medical Toxicology · doi:10.1007/s13181-011-0162-6 · Cited by 470
Amyloid‐Beta Interaction with Mitochondria
Pagani, L., & Eckert, A. (2011) · International Journal of Alzheimer’s Disease · doi:10.4061/2011/925050 · Cited by 309
Emerging roles of ER stress in the etiology and pathogenesis of Alzheimer's disease
Gerakis, Y., & Hetz, C. (2018) · The FEBS Journal · doi:10.1111/febs.14332 · Cited by 226
Research works printed but not linked: 95
- Akgoc, 2015, Bis(monoacylglycero)phosphate: a secondary storage lipid in the gangliosidoses, J. Lipid Res., 56, 1006, 10.1194/jlr.M057851 · DOI
- Alarcon, 2006, Ion channel formation by Alzheimer’s disease amyloid beta-peptide (Abeta40) in unilamellar liposomes is determined by anionic phospholipids, Peptides, 27, 95, 10.1016/j.peptides.2005.07.004 · DOI
- Arbor, 2016, Amyloid-beta Alzheimer targets - protein processing, lipid rafts, and amyloid-beta pores, Yale J. Biol. Med., 89, 5
- Arispe, 2007, Aβ ion channels. Prospects for treating Alzheimer’s disease with Aβ channel blockers, Biochimica et Biophysica Acta (BBA) - Biomembranes, 1768, 1952, 10.1016/j.bbamem.2007.03.014 · DOI · Paper page
- Arispe, 1994, The ability of amyloid beta-protein [A beta P (1-40)] to form Ca2+ channels provides a mechanism for neuronal death in Alzheimer’s disease, Ann. N. Y. Acad. Sci., 747, 256, 10.1111/j.1749-6632.1994.tb44414.x · DOI
- Arispe, 1994, Beta-Amyloid Ca(2+)-channel hypothesis for neuronal death in Alzheimer disease, Mol. Cell. Biochem., 140, 119, 10.1007/BF00926750 · DOI · Paper page
- Arispe, 1993, Giant multilevel cation channels formed by Alzheimer disease amyloid beta-protein [A beta P-(1-40)] in bilayer membranes, Proc. Natl. Acad. Sci. U. S. A., 90, 10573, 10.1073/pnas.90.22.10573 · DOI · Paper page
- Arispe, 1996, Zn2+ interaction with Alzheimer amyloid beta protein calcium channels, Proc. Natl. Acad. Sci., 93, 1710, 10.1073/pnas.93.4.1710 · DOI · Paper page
- Arispe, 1993, Alzheimer disease amyloid beta protein forms calcium channels in bilayer membranes: blockade by tromethamine and aluminum, Proc. Natl. Acad. Sci. U. S. A., 90, 567, 10.1073/pnas.90.2.567 · DOI · Paper page
- Audano, 2018, Mitochondria, lysosomes, and dysfunction: their meaning in neurodegeneration, J. Neurochem., 147, 291, 10.1111/jnc.14471 · DOI
- Bevers, 2016, Getting to the outer leaflet: physiology of phosphatidylserine exposure at the plasma membrane, Physiol. Rev., 96, 605, 10.1152/physrev.00020.2015 · DOI · Paper page
- Blass, 2000, The mitochondrial spiral. An adequate cause of dementia in the Alzheimer’s syndrome, Ann. N. Y. Acad. Sci., 924, 170, 10.1111/j.1749-6632.2000.tb05576.x · DOI
- Bode, 2017, Ion channel formation by Amyloid-β42 oligomers but not Amyloid-β40 in cellular membranes, J. Biol. Chem., 292, 1404, 10.1074/jbc.M116.762526 · DOI · Paper page
- Busche, 2016, Impairments of neural circuit function in Alzheimer’s disease, Philosophical transactions of the Royal Society of London, Series B, Biological sciences, 371
- Camara, 2017, Mitochondrial VDAC1: a key gatekeeper as potential therapeutic target, Front. Physiol., 8, 10.3389/fphys.2017.00460 · DOI · Paper page
- Cascella, 2017, Soluble oligomers require a ganglioside to trigger neuronal calcium overload, J. Alzheimer’s Dis.: JAD, 60, 923, 10.3233/JAD-170340 · DOI
- Cavallo-Medved, 2011, Cathepsin B: basis sequence: mouse, AFCS Nat. Mol. Pages, 2011
- Cenini, 2019, Mitochondria as potential targets in Alzheimer disease therapy: an update, Front. Pharmacol., 10, 902, 10.3389/fphar.2019.00902 · DOI · Paper page
- Cha, 2012, Mitochondria-specific accumulation of amyloid β induces mitochondrial dysfunction leading to apoptotic cell death, PLoS One, 7, e34929, 10.1371/journal.pone.0034929 · DOI · Paper page
- Chakravorty, 2019, Dysfunctional mitochondria and mitophagy as drivers of Alzheimer’s disease pathogenesis, Front. Aging Neurosci., 11, 311, 10.3389/fnagi.2019.00311 · DOI · Paper page
- Chen, 2007, Amyloid-beta-induced mitochondrial dysfunction, J. Alzheimer’s Dis.: JAD, 12, 177, 10.3233/JAD-2007-12208 · DOI · Paper page
- Chen, 2010, Role of mitochondrial amyloid-beta in Alzheimer’s disease, J. Alzheimer’s Dis.: JAD, 20, S569, 10.3233/JAD-2010-100357 · DOI · Paper page
- Cherra, 2008, Autophagy in neuroprotection and neurodegeneration: a question of balance, Future Neurol., 3, 309, 10.2217/14796708.3.3.309 · DOI · Paper page
- Colombini, 2012, VDAC structure, selectivity, and dynamics, Biochim. Biophys. Acta, 1818, 1457, 10.1016/j.bbamem.2011.12.026 · DOI · Paper page
- Comte, 1976, Lipid composition and protein profiles of outer and inner membranes from pig heart mitochondria. Comparison with microsomes, Biochimica et biophysica acta, 419, 271, 10.1016/0005-2736(76)90353-9 · DOI · Paper page
- de Leon, 2007, Imaging and CSF studies in the preclinical diagnosis of Alzheimer’s disease, Ann. N. Y. Acad. Sci., 1097, 114, 10.1196/annals.1379.012 · DOI · Paper page
- Demetrius, 2015, Alzheimer’s disease: the amyloid hypothesis and the Inverse Warburg effect, Front. Physiol., 5, 522, 10.3389/fphys.2014.00522 · DOI
- Diaz, 2009, Small molecule blockers of the Alzheimer Abeta calcium channel potently protect neurons from Abeta cytotoxicity, Proc. Natl. Acad. Sci. U. S. A., 106, 3348, 10.1073/pnas.0813355106 · DOI
- Drews, 2016, Individual aggregates of amyloid beta induce temporary calcium influx through the cell membrane of neuronal cells, Sci. Rep., 6, 31910, 10.1038/srep31910 · DOI
- Durell, 1994, Theoretical models of the ion channel structure of amyloid beta-protein, Biophys. J., 67, 2137, 10.1016/S0006-3495(94)80717-9 · DOI · Paper page
- Evangelisti, 2013, Lipid rafts mediate amyloid-induced calcium dyshomeostasis and oxidative stress in Alzheimer’s disease, Curr. Alzheimer Res., 10, 143, 10.2174/1567205011310020004 · DOI
- Fan, 2020, New insights into the pathogenesis of Alzheimer’s disease, Front. Neurol., 10, 10.3389/fneur.2019.01312 · DOI · Paper page
- Frautschy, 1996, Rodent models of Alzheimer’s disease: rat aβ infusion approaches to amyloid deposits, Neurobiol. Aging, 17, 311, 10.1016/0197-4580(95)02073-X · DOI
- Fukunaga, 2012, GM1 cluster mediates formation of toxic Abeta fibrils by providing hydrophobic environments, Biochemistry, 51, 8125, 10.1021/bi300839u · DOI
- Green, 2011, SnapShot: mitochondrial quality control, Cell, 147, 950, 10.1016/j.cell.2011.10.036 · DOI
- Guicciardi, 2004, Lysosomes in cell death, Oncogene, 23, 2881, 10.1038/sj.onc.1207512 · DOI · Paper page
- Hirakura, 1999, Alzheimer amyloid abeta1-42 channels: effects of solvent, pH, and Congo Red, J. Neurosci. Res., 57, 458, 10.1002/(SICI)1097-4547(19990815)57:4<458::AID-JNR5>3.0.CO;2-4 · DOI
- Hsu, 2009, A novel defense mechanism that is activated on amyloid-β insult to mediate cell survival: role of SGK1-STAT1/STAT2 signaling, Cell Death Differ., 16, 1515, 10.1038/cdd.2009.91 · DOI
- Ikeda, 2011, Mechanism of amyloid beta-protein aggregation mediated by GM1 ganglioside clusters, Biochemistry, 50, 6433, 10.1021/bi200771m · DOI · Paper page
- Jakoš, 2019, Cysteine cathepsins in tumor-associated immune cells, Front. Immunol., 10, 10.3389/fimmu.2019.02037 · DOI
- Jang, 2010, Truncated beta-amyloid peptide channels provide an alternative mechanism for Alzheimer’s Disease and Down syndrome, Proc. Natl. Acad. Sci. U. S. A., 107, 6538, 10.1073/pnas.0914251107 · DOI · Paper page
- Jang, 2013, Alzheimer’s disease: which type of amyloid-preventing drug agents to employ?, Phys. Chem. Chem. Phys.: PCCP, 15, 8868, 10.1039/c3cp00017f · DOI
- Jean, 2015, Stereotaxic infusion of oligomeric amyloid-beta into the mouse Hippocampus, J. visualized Exp.: JoVE, 10.3791/52805 · DOI
- Kagan, 2002, The channel hypothesis of Alzheimer’s disease: current status, Peptides, 23, 1311, 10.1016/S0196-9781(02)00067-0 · DOI · Paper page
- Kavčič, 2017, Lysosomes in programmed cell death pathways: from initiators to amplifiers %, J. Biol. Chem., 398, 289, 10.1515/hsz-2016-0252 · DOI · Paper page
- Kawarabayashi, 2004, Dimeric amyloid beta protein rapidly accumulates in lipid rafts followed by apolipoprotein E and phosphorylated tau accumulation in the Tg2576 mouse model of Alzheimer’s disease, J. Neurosci., 24, 3801, 10.1523/JNEUROSCI.5543-03.2004 · DOI · Paper page
- Kayed, 2013, Molecular mechanisms of amyloid oligomers toxicity, J. Alzheimer’s Dis.: JAD, 33, S67
- Leventis, 2010, The distribution and function of phosphatidylserine in cellular membranes, Annu. Rev. Biophys., 39, 407, 10.1146/annurev.biophys.093008.131234 · DOI · Paper page
- Lin, 2017, Lipid rafts sense and direct electric field-induced migration, Proc. Natl. Acad. Sci. U. S. A., 114, 8568, 10.1073/pnas.1702526114 · DOI
- Lin, 2015, Single-cell screening of cytosolic [Ca(2+)] reveals cell-selective action by the Alzheimer’s Aβ peptide ion channel, Cell Stress Chaperones, 20, 333, 10.1007/s12192-014-0551-2 · DOI
- Lin, 2001, Amyloid beta protein forms ion channels: implications for Alzheimer’s disease pathophysiology, FASEB J.: Off. Pub. Fed. Am. Soc. Exp. Biol., 15, 2433, 10.1096/fj.01-0377com · DOI · Paper page
- Lin, 1999, Amyloid beta protein (1-40) forms calcium-permeable, Zn2+-sensitive channel in reconstituted lipid vesicles, Biochemistry, 38, 11189, 10.1021/bi982997c · DOI · Paper page
- Lin, 2002, Electrophysiologic properties of channels induced by Abeta25-35 in planar lipid bilayers, Peptides, 23, 1215, 10.1016/S0196-9781(02)00057-8 · DOI
- Magrì, 2018, VDAC1 as pharmacological target in Cancer and neurodegeneration: focus on its role in apoptosis, Front. Chem., 6, 108, 10.3389/fchem.2018.00108 · DOI · Paper page
- Mirzabekov, 1994, Channel formation in planar lipid bilayers by a neurotoxic fragment of the beta-amyloid peptide, Biochem. Biophys. Res. Commun., 202, 1142, 10.1006/bbrc.1994.2047 · DOI
- Mosconi, 2007, Early detection of Alzheimer’s disease using neuroimaging, Exp. Gerontol., 42, 129, 10.1016/j.exger.2006.05.016 · DOI · Paper page
- Naldi, 2012, Amyloid β-peptide 25-35 self-assembly and its inhibition: a model undecapeptide system to gain atomistic and secondary structure details of the Alzheimer’s disease process and treatment, ACS Chem. Neurosci., 3, 952, 10.1021/cn3000982 · DOI
- Nixon, 2005, Extensive involvement of autophagy in Alzheimer disease: an immuno-electron microscopy study, J. Neuropathol. Exp. Neurol., 64, 113, 10.1093/jnen/64.2.113 · DOI · Paper page
- Nixon, 2011, Autophagy failure in Alzheimer’s disease--locating the primary defect, Neurobiol. Dis., 43, 38, 10.1016/j.nbd.2011.01.021 · DOI · Paper page
- Okada, 2008, Formation of toxic Abeta(1-40) fibrils on GM1 ganglioside-containing membranes mimicking lipid rafts: polymorphisms in Abeta(1-40) fibrils, J. Mol. Biol., 382, 1066, 10.1016/j.jmb.2008.07.072 · DOI
- Parodi, 2010, Beta-amyloid causes depletion of synaptic vesicles leading to neurotransmission failure, J. Biol. Chem., 285, 2506, 10.1074/jbc.M109.030023 · DOI · Paper page
- Pollard, 1995, Ion channel hypothesis for Alzheimer amyloid peptide neurotoxicity, Cell. Mol. Neurobiol., 15, 513, 10.1007/BF02071314 · DOI
- Pollard, 1993, A new hypothesis for the mechanism of amyloid toxicity, based on the calcium channel activity of amyloid beta protein (A beta P) in phospholipid bilayer membranes, Ann. N. Y. Acad. Sci., 695, 165, 10.1111/j.1749-6632.1993.tb23046.x · DOI
- Reddy, 2013, Is the mitochondrial outermembrane protein VDAC1 therapeutic target for Alzheimer’s disease?, Biochimica et Biophysica Acta (BBA) – Mol. Basis Dis., 1832, 67, 10.1016/j.bbadis.2012.09.003 · DOI
- Rhee, 1998, Amyloid beta protein-(1-42) forms calcium-permeable, Zn2+-sensitive channel, J. Biol. Chem., 273, 13379, 10.1074/jbc.273.22.13379 · DOI · Paper page
- Samara, 2008, Autophagy is required for necrotic cell death in Caenorhabditis elegans, Cell Death Differ., 15, 105, 10.1038/sj.cdd.4402231 · DOI · Paper page
- Schmitt, 2012, Insights into mitochondrial dysfunction: aging, amyloid-β, and tau-A deleterious trio, Antioxid. Redox Signal., 16, 1456, 10.1089/ars.2011.4400 · DOI · Paper page
- Schubert, 1997, Serpins inhibit the toxicity of amyloid peptides, Eur. J. Neurosci., 9, 770, 10.1111/j.1460-9568.1997.tb01425.x · DOI · Paper page
- Sciacca, 2012, Two-step mechanism of membrane disruption by Aβ through membrane fragmentation and pore formation, Biophys. J., 103, 702, 10.1016/j.bpj.2012.06.045 · DOI · Paper page
- Segawa, 2015, An apoptotic’ Eat Me’ signal: phosphatidylserine exposure, Trends Cell Biol., 25, 639, 10.1016/j.tcb.2015.08.003 · DOI · Paper page
- Shirwany, 2007, The amyloid beta ion channel hypothesis of Alzheimer’s disease, Neuropsychiatr. Dis. Treat., 3, 597
- Simmons, 1993, Amyloid beta peptides act directly on single neurons, Neurosci. Lett., 150, 133, 10.1016/0304-3940(93)90519-Q · DOI
- Smith, 2017, Binding sites for Amyloid-β oligomers and synaptic toxicity, Cold Spring Harb. Perspect. Med., 7, 10.1101/cshperspect.a024075 · DOI · Paper page
- Sokolov, 2006, Soluble amyloid oligomers increase bilayer conductance by altering dielectric structure, J. Gen. Physiol., 128, 637, 10.1085/jgp.200609533 · DOI · Paper page
- Takuma, 2004, Amyloid Beta peptide-induced cerebral neuronal loss is mediated by Caspase-3 in vivo, J. Neuropathol. Exp. Neurol., 63, 255, 10.1093/jnen/63.3.255 · DOI
- Teixeira, 2019, Future therapeutic perspectives into the Alzheimer’s disease targeting the oxidative stress hypothesis, Molecules, 24, 10.3390/molecules24234410 · DOI
- Teplow, 2013, On the subject of rigor in the study of amyloid β-protein assembly, Alzheimers Res. Ther., 5, 39, 10.1186/alzrt203 · DOI
- Thinnes, 2010, Amyloid Aß, cut from APP by ß-secretase BACE1 and γ-secretase, induces apoptosis via opening type-1 porin/VDAC in cell membranes of hypometabolic cells-A basic model for the induction of apoptosis!?, Mol. Genet. Metab., 101, 301, 10.1016/j.ymgme.2010.07.007 · DOI
- Thinnes, 2015, Plasmalemmal VDAC-1 corroborated as amyloid Aß-receptor, Front. Aging Neurosci., 7, 188, 10.3389/fnagi.2015.00188 · DOI
- Todkar, 2019, Mitochondrial interaction with the endosomal compartment in endocytosis and mitochondrial transfer, Mitochondrion, 49, 284, 10.1016/j.mito.2019.05.003 · DOI
- Turk, 1995, Regulation of the activity of lysosomal cysteine proteinases by pH-induced inactivation and/or endogenous protein inhibitors, cystatins, Biol. Chem. Hoppe-Seyler, 376, 225, 10.1515/bchm3.1995.376.4.225 · DOI · Paper page
- Turk, 2002, Apoptotic pathways: involvement of lysosomal proteases, Biol. Chem., 383, 1035, 10.1515/BC.2002.112 · DOI · Paper page
- Van Dam, 2011, Animal models in the drug discovery pipeline for Alzheimer’s disease, Br. J. Pharmacol., 164, 1285, 10.1111/j.1476-5381.2011.01299.x · DOI · Paper page
- Vestergaard, 2010, Cholesterol, lipids, amyloid Beta, and Alzheimer’s, Curr. Alzheimer Res., 7, 262, 10.2174/156720510791050821 · DOI
- Whittington, 2017, Impaired resolution of inflammation in Alzheimer’s disease: a review, Front. Immunol., 8, 1464, 10.3389/fimmu.2017.01464 · DOI
- Wolfe, 2013, Autophagy failure in Alzheimer’s disease and the role of defective lysosomal acidification, Eur. J. Neurosci., 37, 1949, 10.1111/ejn.12169 · DOI · Paper page
- Wong, 2010, Autophagy gone awry in neurodegenerative diseases, Nat. Neurosci., 13, 805, 10.1038/nn.2575 · DOI · Paper page
- Wouters, 2016, Cathepsin B pulls the emergency brake on cellular necrosis, Cell Death Dis., 7, e2170, 10.1038/cddis.2016.76 · doi:10.1038/cddis.2016.76
- Wu, 2019, Mitochondrial dysfunction in neurodegenerative diseases and drug targets via apoptotic signaling, Mitochondrion, 49, 35, 10.1016/j.mito.2019.07.003 · DOI · Paper page
- Yang, 1998, Loss of endosomal/lysosomal membrane impermeability is an early event in amyloid Abeta1-42 pathogenesis, J. Neurosci. Res., 52, 691, 10.1002/(SICI)1097-4547(19980615)52:6<691::AID-JNR8>3.0.CO;2-3 · doi:10.1002/(sici)1097-4547(19980615)52:6<691::aid-jnr8>3.0.co;2-3
- Yang, 2007, Induction of autophagy in neurite degeneration of mouse superior cervical ganglion neurons, Eur. J. Neurosci., 26, 2979, 10.1111/j.1460-9568.2007.05914.x · DOI
- Yao, 2018, Inhibiting autophagy reduces retinal degeneration caused by protein misfolding, Autophagy, 14, 1226, 10.1080/15548627.2018.1463121 · DOI
- Youle, 2011, Mechanisms of mitophagy, Nature reviews, Mol. cell Boil., 12, 9
- Zaretsky, 2020, Degradation products of amyloid protein: are they the culprits?, Curr. Alzheimer Res., 17, 869, 10.2174/1567205017666201203142103 · DOI
- Zaretsky, 2020, Flow cytometry method to quantify the formation of beta-amyloid membrane ion channels, Biochimica et biophysica acta. Biomembranes
Cited by
Wang, J., Fourriere, L., & Gleeson, P. A. (2024) · Biochemical Journal · doi:10.1042/bcj20240056 · Cited by 27
Metadata
- Authors
- Zaretsky, D. V., & Zaretskaia, M. V.
- ORCID
- Zaretsky, Dmitry V.
- Venue
- Neuroscience Letters
- Publisher
- Elsevier BV
- Published
- 2021-06
- Volume
- 756
- Pages
- 135959
- ISSN
- 0304-3940
- Cited by
- 28
- References
- 16
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- doi.org/10.15223/policy-017 (stm-asf)
- doi.org/10.15223/policy-037 (stm-asf)
- doi.org/10.15223/policy-012 (stm-asf)
- doi.org/10.15223/policy-029 (stm-asf)
- doi.org/10.15223/policy-004 (stm-asf)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Mini-review: amyloid degradation toxicity hypothesis of Alzheimer's disease. https://app.cochat.ai/papers/10.1016/j.neulet.2021.135959
- The paper
- Zaretsky, D. V., & Zaretskaia, M. V. (2021). Mini-review: amyloid degradation toxicity hypothesis of Alzheimer's disease. Neuroscience Letters. https://doi.org/10.1016/j.neulet.2021.135959
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.